title: Critical appraisal of mass DEC compliance in a district of west Bengal.
abstract: A cross sectional study was carried out to assess drug compliance after Mass Drug Administration of DEC and the factors responsible for poor compliance among the population of Murshidabad district of West Bengal during Jan 2009. Total study unit were 120 families covering 3 villages and one municipality ward area (30 families from each area). As a part of Revised Filaria control strategy, MDA programme was implemented in Murshidabad district from 29th-31st December 2008. Result revealed that total covered population were 601, out of which 571 were eligible population for Mass drug administration (6 Pregnant women and <2 years age groups (24) were excluded). Drug distribution rate was 91.8%. Overall drug compliance was 42.3%. Total number of defaulters was 330 (57.7%). Non compliance was highest (75.5%) in urban area. Defaulters was more among male than female. Factors responsible for defaulters were no motivation (24.7%), drugs not supplied (22.5%), absence at home (13.5%), no faith (10.1%), fear of side effects (10.1%) and others (Forgotten, lack of prior IEC etc), illness, wrong information were 7.8%, 7.3%, 3.9% respectively. Majority has no side effects, only dizziness (3.3%), headache (1.7%), vomiting and others (4.1%) were experienced by the people after consumption of drugs. On an average 40% families were aware about ELF & transmission of disease. Only 43.7% of community members were informed about MDA by Health Workers prior to the implementation of MDA programme.
authors.forename: Anima
authors.initials: A
authors.lastname: Haldar
authors.forename: Urmila
authors.initials: U
authors.lastname: Dasgupta
authors.forename: Rama Prasad
authors.initials: RP
authors.lastname: Ray
authors.forename: Sankar Nath
authors.initials: SN
authors.lastname: Jha
authors.forename: Santanu
authors.initials: S
authors.lastname: Haldar
authors.forename: Salil Kumar
authors.initials: SK
authors.lastname: Bhattacharya
mesh_terms: D000328:Adult; D003430:Cross-Sectional Studies; D003710:Demography; D004049:Diethylcarbamazine / Q000008:administration & dosage* / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004605:Elephantiasis, Filarial / Q000517:prevention & control*; D005260:Female; D005369:Filaricides / Q000008:administration & dosage* / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011247:Pregnancy
chemical_list: D005369:Filaricides; D004049:Diethylcarbamazine